Fabian Zanella's Biography

Fabian Zanella, Director of Research and Development, StemoniX Inc.

Fabian Zanella’s scientific expertise is focused on cell-based assay development, and applications of human induced pluripotent stem cells (hiPSCs)-derived cells in drug screening and disease modelling. Fabian joined the core founding team StemoniX as their first employee and has been directly involved in steering the R&D activities at StemoniX in the design, validation and implementation of high throughput physiologically relevant screening platforms involving hiPSC-derived cardiomyocytes and hiPSC-derived cells from the neuronal lineage.

Adding Structure to High Throughput hiPSC-derived Cardiac and Neuronal Models for Improved Physiological Relevance and Performance

Friday, 5 October 2018 at 11:30

Add to Calendar ▼2018-10-05 11:30:002018-10-05 12:30:00Europe/LondonAdding Structure to High Throughput hiPSC-derived Cardiac and Neuronal Models for Improved Physiological Relevance and Performance3D-Culture and Organoids in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Here we provide case studies how on induced pluripotent stem cell (hiPSC)-based platforms structurally engineered for greater physiological relevance can elevate performance in drug discovery applications. microBrain^® 3D comprises cortical neural spheroids that feature high functionality with robust spontaneous activity and expected responses to established neuromodulators. microHeart^® allows cardiomyocytes to adopt cell geometries and intercellular organization that resemble native heart tissue, translating into to differential pharmacological response to known cardioactive compounds.

Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/London3D-Culture and Organoids3D-Culture and Organoids in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors